Highly variable drug product [PK / PD]

posted by jag009  – NJ, 2013-02-07 16:22 (4476 d 08:54 ago) – Posting: # 9988
Views: 8,299

Hi Dr_Dan,

❝ Please keep in mind: HVD ≠ HVDP

❝ HVDPs are products in which the drug must not necessaribly be highly variable, but the product could be of poor pharmaceutical quality => high within-formulation variability!


Understood and totally agree. I was just curious on what basis one justifies the need for a full four way replicate design study. I just don't see it unless one has identified the issues based on 1) quality issue - variation observed from dissolution/content uniformity/etc etc 2) running a pilot test only 2x2 or full replicate study.

John

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
86 visitors (0 registered, 86 guests [including 8 identified bots]).
Forum time: 02:17 CEST (Europe/Vienna)

If you shut your door to all errors
truth will be shut out.    Rabindranath Tagore

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5